BIOTECHNOLOGY MARKET ANALYSIS (2020-2027) - PowerPoint PPT Presentation

About This Presentation



Read here the market research report on the “Biotechnology Market" published by CMI Team – PowerPoint PPT presentation

Number of Views:98


Transcript and Presenter's Notes


  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Biotechnology Market, By Application
    (Biopharmaceutical, Bio services,
    Bio-Agriculture, Research), By Technology
    (Fermentation, Tissue engineering, PCR
    technology, Nanobiotechnology, Chromatography,
    DNA Sequencing Technology, Cell Based Assay,
    Other Technologies), and By Region (North
    America, Latin America, Europe, Asia Pacific,
    Middle East Africa) - Size, Share, Outlook, and
    Opportunity Analysis, 2020 - 2027

  • Biotechnology can be segregated into four basic
    systems. The first system deals with use of
    biotechnology in pharmaceuticals. The next system
    involves the use of biotechnology to produce new
    chemicals and industrial processes. The next
    important segment comprises the use of
    biotechnology in the manufacturing of seeds
    and genetically modified crops. The last segment
    is the least developed one and involves the use
    of biotechnology in marine applications. These
    applications of biotechnology are categorized as
    biopharmacy, bioagriculture, bioindustrial and

  • The global biotechnology market is estimated to
    account for US 1,303.1 Bn in terms of value by
    the end of 2027.

Global Biotechnology Market Drivers
  • Increasing investment in the pharmaceutical
    sector is expected to propel growth of the global
    biotechnology market over the forecast period.
    For instance, according to The European
    Federation of Pharmaceutical Industries and
    Associations Key Data 2019, the pharmaceutical
    sector in Europe invested US 19, 509 million in
    2000, which increased to US 39,895 million
    (est.) in 2018.
  • Moreover, increasing prevalence of chronic
    disorders is also expected to aid in growth of
    the market. For instance, according to a study,
    Projections of cancer prevalence in the United
    Kingdom, 2010-2040, published in British Journal
    of Cancer, the number of people suffering from
    cancer in the U.K. is expected to increase from
    2.5 million in 2015 to 4 million by 2030. 

  • North America held dominant position in the
    global biotechnology market in 2019, accounting
    for 41.3 share in terms of value, followed by
    Europe and Asia Pacific, respectively.

  • Figure 1 Global Biotechnology Market Share ()
    Value, By Region, 2019

Global Biotechnology Market Restraints
  • Ethical issues associated with clinical trials
    are expected to hinder growth of the market.
    Clinical trials of drugs include sets of tests
    that are conducted to generate data regarding the
    effects, safety and side-effects of the drugs.
    These trials are conducted only after sufficient
    information is gathered about the drug which has
    been developed. However, lack of regulations in
    some regions have led to a large number of deaths
    over the past few years. In addition, faulty
    practices during clinical trials such as lack of
    observation, non-disclosure of the risks involved
    in the drug trial and trials conducted without
    permission from the authorized bodies have added
    to the ethical concerns of these trials.

  • Moreover, high investments are required in drug
    research and development, which is also expected
    to limit the market growth. For instance, , the
    cost of drug development was US 2.6 billion,
    which included average out-of-pocket costs of US
    1.4 billion and time costs of US 1.2 billion,
    according to a study by the Tufts Center for the
    Study of Drug Development published in the
    Journal of Health Economics in May 2019.

(No Transcript)
Global Biotechnology Market Opportunities
  • Increasing adoption of biosimilars is expected to
    offer lucrative growth opportunities for players
    in the global biotechnology market. For instance,
    according to the Association for Accessible
    Medicines, the launch of new biosimilars is
    expected to save US 250 billion in healthcare
    cost during 2016-2025.   
  • Moreover, RD in personalized medicine is also
    expected to aid in growth of the market. For
    instance, in January 2020, researchers at
    Biomedical Research Institute, MEDIPOST Co.,
    Ltd., South Korea, reported analysis of the
    effects of spheroid umbilical cord blood-derived
    mesenchymal stem cells (MSCs) and suggested a new
    therapeutic approach, 3D spheroid formation of
    MSCs, in order to enhance the regeneration
    process in the course of osteoarthritis.

  • The global biotechnology market was valued at US
    518.3 Bn in 2019 and is forecast to reach a value
    of US 1,303.1 Bn by 2027 at a CAGR of 12.3
    between 2020 and 2027.

  • Figure 2 Global Biotechnology Market Value (US
    Bn), 2016 2027

Market Trends/Key Takeaways
  • The market is witnessing increasing investment
    for RD of vaccines. For instance, in May 2020,
    Thermo Fisher Scientific Inc. announced US 180
    million project to more than double the companys
    commercial viral vector capacity to support
    increasing demand for the development and
    manufacture of gene therapies and vaccines.
  • Emergence of Covid-19 is boosting growth of the
    market. For instance, in March 2020, IQVIA and
    Quest Diagnostics, through its joint venture Q2
    Solutions, collaborated with the University of
    Texas Medical Branch to develop a novel assay for
    COVID-19 tests for rapid development of a
    Coronavirus vaccine.

  • Figure 3 Value Chain Analysis

Global Biotechnology Market Competitive
  • Major players operating in the global
    Biotechnology market include, Abbott
    Laboratories, Amgen Inc., GlaxoSmithKline,
    Johnson and Johnson, Merck, Novartis, Novo
    Nordisk, Pfizer, Inc., Roche, and Sanofi

Global Biotechnology Market Key Developments
  • Major players in the market are focused on
    adopting collaboration strategies to expand their
    product portfolio. For instance, in January 2020,
    QIAGEN N.V. collaborated Amgen to develop
    tissue-based companion diagnostics for Amgens
    investigational cancer treatment AMG 510 to
    identify patients with cancers that have the KRAS
    G12C mutation.
  • Major players in the market are also focused on
    launching new products to expand their product
    portfolio. For instance, in June 2019, Abbott
    Laboratories launched Afinion HbA1c Dx test, a
    3-minute, in-office A1c blood test for diagnosing

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//
Write a Comment
User Comments (0)